Statin-induced rhabdomyolysis
- 1 August 2006
- journal article
- case report
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 31 (2) , 177-180
- https://doi.org/10.1016/j.jemermed.2005.08.020
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Statin-Associated MyopathyJAMA, 2003
- Cytochrome P450 Drug Interactions Within the HMG-CoA Reductase Inhibitor ClassDrug Safety, 2003
- Interactions Between Cyclosporin and Lipid-Lowering DrugsDrugs, 2003
- FDA Adverse Event Reports on Statin-Associated RhabdomyolysisAnnals of Pharmacotherapy, 2002
- Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 2002
- Effects of HMG-CoA Reductase Inhibitors on Skeletal MuscleDrug Safety, 2002
- Clinically relevant differences between the statins: implications for therapeutic selectionThe American Journal of Medicine, 2001
- Drug Treatment of Lipid DisordersNew England Journal of Medicine, 1999
- Metabolism and Drug Interactions of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Transplant Patients: Are the Statins Mechanistically Similar?Pharmacology & Therapeutics, 1998
- Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses*Clinical Pharmacology & Therapeutics, 1997